MedPath

Evaluation of the clinical usefulness of rupatadine in patients with seasonal allergic rhinitis

Not Applicable
Conditions
Seasonal allergic rhinitis
Registration Number
JPRN-UMIN000031360
Lead Sponsor
Medical Corporation Shinanokai, Shinanozaka Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient with nasal disorders and/or infectious diseases. 2) Patient with non-allergic rhinitis. 3) Patient who underwent nasal surgery, including laser or coagulation surgery to improve nasal symptoms for less than one year before the agreement. 4) Patient with uncontrolled asthma. 5) Patient who has the hypersensitivity to antihistamine including rupatadine. 6) Following medications and treatments are prohibited before the start of the study. Antihistamine, leukotriene receptor antagonist, anti-thromboxane A2, and any antirhinitis medications. Steroid preparation (oral, injection, inhalation, and nasal drop), vasoconstictor (eye or nasal drop), parasympathetic nerve blocker (anti-cholinergic drug), biological preparation, immunosuppressive drug and any other drugs with similar pharmacological properties (eg Chinese herbal medicine), laser surgery, coagulation surgery, and nasal irrigation with normal saline. 7) Patient who is undergoing immunotherapy. 8) Patient with a liver or renal dysfunction. 9) Patient with severe complications. 10)Pregnant women or breast-feeding women, and patients who may be pregnant. 11) Patient who is judged to be ineligible for participation in the study by the clinical investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment satisfaction of the patient on the 11th day
Secondary Outcome Measures
NameTimeMethod
1) Total nasal symptom score 2) Night nasal congestion score 3) QOL score
© Copyright 2025. All Rights Reserved by MedPath